Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Remifentanil for Analgesia in Multiple Trauma Patients
ChiCTR2100046500Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in polytrauma comparing Nalbuphine monotherapy, Remifentanil monotherapy and Nalbuphine + Remifentanil combination (3 arms). Primary endpoint: Morphine consumption to maintain ideal analgesia. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
nalbuphineremifentanil
03
Conditions
polytrauma
Beyond the preview
Go deeper on ChiCTR2100046500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046500.